Weight management
Tirzepatide Injections
Dual-pathway injectable support for a clinician-guided weight plan.*
Tirzepatide injections support appetite regulation and clinically guided weight management through dual-pathway activity in a once-weekly format.*
*Results and eligibility differ by individual. Prescription treatment requires an evaluation by an independent licensed provider. Compounded medications are not FDA-approved and are prepared by a licensed pharmacy when clinically appropriate.
At a glance
What this treatment offers*
Tirzepatide
Dual-pathway injectable format
An injectable format supports appetite regulation through GIP and GLP-1 pathways.*
Individual plan
Ongoing provider guidance
A provider reviews response and tolerability and adjusts the plan when clinically appropriate.
Treatment information
What to know about this treatment
Overview
Tirzepatide injections support appetite regulation and a clinician-guided weight management plan through a once-weekly injectable format.* Treatment includes provider evaluation and ongoing guidance based on individual response and tolerability.
How it works
Tirzepatide activates GIP and GLP-1 pathways involved in appetite and food intake.* A licensed provider determines eligibility, selects a starting plan, and adjusts treatment when clinically appropriate.
Who it is for
This option is designed for eligible adults whose health history and weight-related goals support prescription treatment. A provider reviews medical history, current medicines, pregnancy plans, prior weight treatment, and other clinical factors before prescribing.
Important safety information
Tell the provider about a personal or family history of medullary thyroid carcinoma or MEN 2, pancreatitis, gallbladder or kidney problems, severe stomach symptoms, pregnancy plans, and all current medicines. Seek medical care for severe or persistent abdominal pain, a serious allergic reaction, or concerning symptoms. Compounded tirzepatide is not FDA-approved.
Formulation
Active ingredient information
Formulation and dose are personalized during your clinical review, based on your health history and current medicines.
Active ingredient
Tirzepatide
GIP and GLP-1 receptor agonist
Supports appetite regulation through GIP and GLP-1 pathways as part of a clinician-guided weight management plan.*
Frequently asked questions
Common questions, clearly answered
Private clinician-guided care
Take the next step with a private clinical evaluation.
Tell us about your goals and health history in a secure online visit. A licensed provider will decide whether treatment is appropriate.